Top Navigation
Global
Choose your region
Don't see your region/country listed? Visit our global website
Related content
Chief Human Resources Officer Stephanie Franklin discusses our unique culture at Vertex and how we bring our culture to life.
Our CEO and President, Reshma Kewalramani shares her thoughts on how Vertex is rethinking work and education in an extremely competitive talent market
Join us as we celebrate 15 years of giving back at Vertex.
In this section
Our scientists don’t see the impossible as an obstacle; they see it as a good place to start
See where our scientific discoveries happen
Volunteers who participate in clinical trials help make new medicines a reality
Information about our Early Access program and how we evaluate requests
Instructions on how to submit a report
We work with the kidney disease community to ensure their voices are represented in all that we do
See how we're engaging with the sickle cell disease community
Read more about how we operate our business responsibly, and how in 2023 we created more ways to positively impact patients, employees, our communities and the environment
Discover how we're inspiring and equipping the next generation to love science and pursue a career in STEM
Explore our commitment to limiting our environmental impacts and operating our business in a sustainable manner
Chief Human Resources Officer Stephanie Franklin discusses Vertex’s inclusive benefits and how they are helping Vertexians.
Our commitment to inclusion, diversity and equity (ID&E) is longstanding and achieving our ambition takes collective action and shared ownership. Learn more about our approach from Vice President of Talent and ID&E Diana Cruz Solash.
Discover more about our relentless efforts to improve the lives of patients, employees and our communities.
We are relentless in our quest to improve the lives of people living with serious diseases. Thanks to the dedication of teams led by Paul Negulescu, Sabine Hadida and Fred Van Goor, our medicines have profoundly impacted the cystic fibrosis community, earning recognition such as the prestigious Breakthrough Prize.
Listen to our new podcast, Targeting the Toughest Diseases, created in partnership with Bloomberg Media Studios, to learn about the innovative tools, methods and unique philosophy we use in our search for treatments and cures.